Relapsed/Refractory AML: Why and How to Treat? | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Relapsed/Refractory AML: Why and How to Treat?

Presenter(s): 
Topic(s): 
Acute Myeloid Leukemia (AML)
Presentation Date: 
Wed, 08/21/2019 - 8:00pm (EDT)

In this webinar, Dr. Elie Traer from OHSU Knight Cancer Institute in Portland, OR will discuss what is refractory/relapsed AML, how it is diagnosed, affects on treatments and what this diagnosis means for patients. Participants will have the opportunity to ask Dr. Traer their questions.